ليست عنوان مقالات لاتين Canadian petrochemical plants blamed for gender imbalance CANDLE: The New Burnup Strategy

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Canadian petrochemical plants blamed for gender imbalance

2

Canadian practitionersʹ perception of research work investigating the cost premiums, long-term costs and health and productivity benefits of green buildings

3

Canadian programme reverses high anaemia incidence

4

Canadian prohibition against immigrants with disabilities is challenged

5

Canadian province opens door to two-tier health service

6

Canadian provincial health ministers press for change

7

Canadian R&D abroad management practices

8

Canadian Red Cross fires secretary-general

9

Canadian Red Cross found negligent

10

Canadian regulation of private security in an international perspective

11

Canadian regulatory approach to ensuring the implementation of effective ageing management programs for nuclear power plants

12

Canadian report quantifies cost of medical errors

13

Canadian researchers awarded record damages

14

Canadian researchers respond to CMAJ crisis

15

Canadian respirologistʹs murder trial appeal quashed

16

Canadian retailing strategy: Challenges and change : William A. Crowe and Mark E. Siemonsen Nelson Canada, Scarborough, Ontario: (1996) 444 pp. ISBN 0 17 6055770

17

Canadian scientists urge government to develop antibiotic plan

18

Canadian scientists vindicated over whistleblowing

19

Canadian settlement guarantees world medical isotope supply

20

Canadian soldiers and doctors face torture allegations

21

Canadian space environment program and international living with a star Original Research Article

22

Canadian spending on prescription drugs is increasing

23

Canadian Steinernematid (Nematoda) Isolates and Their Infectivity, under Cold Conditions, to Greater Wax Moth (Galleria mellonella) Larvae

24

Canadian suppliers of mining goods and services: links between Canadian mining companies and selected sectors of the Canadian economy: Minerals and Metals Sector; Natural Resources Canada, 2000, xvi + 58pp., free upon request, ISBN 0-662-84954-7, softcove

25

Canadian tourist information and the UK: plans and perceptions

26

Canadian universities go shopping for research scientists

27

Canadian university publishes new rules to protect scientists

28

Canadian waters provide critical foraging habitat for leatherback sea turtles Original Research Article

29

Canadians allow targeted transfusion

30

Canadians are fighting fit, says government report

31

Canadians finally fill regulatory void with stem-cell bill

32

Canadians in Alabama: a perceptual study of dialect acquisition in adults

33

Canadians inquire into drug licensing

34

Canadians propose overhaul of research-ethics guidelines

35

Canadians still stung by WHOʹs SARS travel advisory

36

Canagliflozin-associated Peripheral Vascular Ischemia: A Case Report

37

Canal blocking strategies for hydrological restoration of degraded tropical peatlands in Central Kalimantan, Indonesia

38

Canal configuration of mandibular first premolars in an Egyptian population

39

Canal Configuration of Mesiobuccal Roots in Permanent Maxillary First Molars in Iranian Population: A Systematic Review

40

Canal of Nuck hernias

41

Canal preparation for prosthetic radial head replacement: rasping versus reaming

42

Canal surfaces in 4-dimensional Euclidean space

43

Canal Transportation and Centering Ability of ProTaper and SafeSider in Preparation of Curved Root Canals: A CBCT Evaluation

44

Canal Transportation and Centering Ability of Reciproc Blue, WaveOne Gold and ProTaper Next in Simulated Curved Canals

45

Canal Transportation and Centering Ability of Twisted File and Reciproc: A Cone-Beam Computed Tomography Assessment

46

Canal Transportation and Centering after Using PathFile and R-Pilot in Mesiobuccal Canals of Maxillary Molars Using Cone-Beam Computed Tomography

47

Canal Transportation and Centring Ability of Reciproc and Reciproc Blue With or Without Use of Glide Path Instruments: A CBCT Study

48

Canal water treatment with rapid sand filtration

49

Canaletto’s paintings open a new window on the relative sea-level rise in Venice

50

Canalicular adenoma of the hard palate: A rare case report

51

Canalicular and Naolacrimal Duct Blockage: An Ocular ide Effect Aociated With the Antineoplatic Drug -1

52

Canalicular bile formation: beyond single transporter functions

53

Canalicular fluid flow induced by bending of a long bone

54

Canalis Sinuosus Damage after Immediate Dental Implant Placement in the Esthetic Zone

55

Canalization as a non-genetic source of adaptiveness during morphogenesis: experimental evidence from analysis of reproductive development in Sorghum bicolor

56

Canalization of development and ecdysteroid timing during the last instar in lubber grasshoppers

57

Canals and Communities. Small-scale Irrigation Systems, Edited by J. Mabry, University of Arizona Press, 1996. ISBN 0816515921, pp. 273

58

Canard phenomenon for an SIS epidemic model with nonlinear incidence

59

Canard solution and its asymptotic approximation in a second-order nonlinear singularly perturbed boundary value problem with a turning point

60

Canard solutions of two-dimensional singularly perturbed systems

61

Canards and mixed-mode oscillations in a forest pest model

62

63

CANARD-WING INTERACTIONS IN SUBSONIC FLOW

64

Canary current upwelling: More or less?

65

Canary in the coalmine: Norwegian attitudes towards climate change and extreme long-haul air travel to Aotearoa/New Zealand

66

Canary islands aborigin sex determination based on mandible parameters contrasted by amelogenin analysis

67

Canataxpropellane, a novel taxane with a unique polycyclic carbon skeleton (tricyclotaxane) from the needles of Taxus canadensis

68

Canavalia ensiformis urease, Jaburetox and derived peptides form ion channels in planar lipid bilayers

69

Canavan disease: a monogenic trait with complex genomic interaction

70

Canavanine content in sword beans (Canavalia gladiata): Analysis and effect of processing

71

CaNb2O6 ceramics prepared by a reaction-sintering process

72

c-ANCA as a marker of Wegenerʹs disease

73

c-ANCA as a serological pitfall

74

C-ANCA Positive Vasculitis in a Case of Amyloidosis

75

Cancarb appoints European agents for its Thermax thermal blacks

76

CAN-catalyzed syntheses of 3,4-dihydroquinoxalin-2-amine derivatives based on isocyanides

77

CAN-catalyzed three-component reaction between anilines and alkyl vinyl ethers: stereoselective synthesis of 2-methyl-1,2,3,4-tetrahydroquinolines and studies on their aromatization

78

79

Canceling out both the real and the spectral lines

80

Canceling print serials in favor of electronic: criteria for decision making

81

Cancellable biometerics featuring with tokenised random number

82

Cancellable biometrics and annotations on BioHash

83

Cancellation among finite unary algebras Original Research Article

84

Cancellation and Focus: The Role of Shared and Unique Features in the Choice Process

85

Cancellation Conditions for Finite Two-Dimensional Additive Measurement

86

Cancellation errors in an integral for calculating magnetic field from reduced scalar potential

87

Cancellation in cyclic consecutive systems

88

Cancellation is exponentially powerful for computing the determinant

89

Cancellation of bending-induced birefringence in single-mode fibers: application to Faraday sensors

90

Cancellation of Capacitor Parasitic Parameters for Noise Reduction Application

91

Cancellation of digraphs over the direct product

92

Cancellation of elective oral and maxillofacial operations

93

Cancellation of Elective Surgeries in a Tertiary Care Hospital in North India

94

Cancellation of fine-structure splitting in quantum dots by a magnetic field

95

Cancellation of Harmonic Interference by Baseline Shifting of Wavelet Packet Decomposition Coefficients

96

Cancellation of heat effects in catalytic distillation

97

Cancellation of image crosstalk in time-sequential displays of stereoscopic video

98

Cancellation of Infrared Divergences at Finite Temperature

99

cancellation of land certificate based on the court decision in indonesian legal system

100

CANCELLATION OF MASS-LOADING EFFECTS OF TRANSDUCERS AND EVALUATION OF UNMEASURED FREQUENCY RESPONSE FUNCTIONS

101

Cancellation of operations in Saudi Arabian hospitals: Frequency, reasons and suggestions for improvements

102

Cancellation of polarized impulsive noise using an azimuth-dependent conditional mean estimator

103

Cancellation of projective modules over regular rings with comparability Original Research Article

104

Cancellation of renormalon ambiguities in the heavy quark effective theory Original Research Article

105

Cancellation of second-order intermodulation distortion and enhancement of IIP2 in common-source and common-emitter RF transconductors

106

Cancellation of Series-Loss Resistance in UWB Active Inductors using RC Feedback

107

Cancellation of Simulated Environmental Noise as a Tool for Measuring Vocal Performance During Noise Exposure

108

Cancellation of star light generated by a nearby star–planet system upon detection with a rotationally-shearing interferometer

109

Cancellation of Sudakov logarithms in radiative decays of quarkonia Original Research Article

110

Cancellation of the Heating Piston Effect by Convective Enhancement of a Cooling Piston Effect

111

Cancellation problem of preconditioning method at low Mach numbers

112

Cancellation properties for quotient divisible groups

113

Cancellation properties of products of graphs

114

Cancellation Properties of Projective Modules over Laurent Polynomial Rings Original Research Article

115

Cancellation Properties of Projective Modules over Laurent Polynomial Rings Original Research Article

116

Cancellation provisions in Australiaʹs Commonwealth-managed fisheries

117

Cancellation task in very low educated people

118

Cancellation techniques in underwater scattering of acoustic signals

119

Cancellation Theorems Related to Conjectures of Alperin and Dade

120

Cancellations in ambulatory day surgery: Ten years observational study

121

Cancellations in day-case ENT surgery

122

Cancellations in neutrinoless double beta decay and the neutrino mass matrix Original Research Article

123

Cancellative pairs of families of sets

124

CancellativeAbelianMonoids and Related Structures in Refutational Theorem Proving (Part I)

125

CancellativeAbelianMonoids and Related Structures in Refutational Theorem Proving (Part II)

126

Cancellativity properties for t-norms and t-subnorms

127

Cancelled IGF-1 trials bode ill for diabetic patients

128

Cancelling Jüttner distributions for space-like freeze-out

129

Cancelling quadratic divergences without supersymmetry Original Research Article

130

Cancelling vibrations in flexible articulated structures using non-causal inverse dynamics

131

Cancellous and cortical bone mineral density around an elastic press-fi t socket in total hip arthroplasty

132

Cancellous and cortical morselized allograft in revision total hip replacement:: A biomechanical study of implant stability

133

Cancellous bone architecture: Advantages of nonorthogonal trabecular alignment under multidirectional joint loading

134

Cancellous bone biomechanics

135

Cancellous bone lamellae strongly affect microcrack propagation and apparent mechanical properties: Separation of patients with osteoporotic fracture from normal controls using a 2D nonlinear finite element method (biomechanical stereology)

136

Cancellous bone mechanical properties from normals and patients with hip fractures differ on the structure level, not on the bone hard tissue level

137

Cancellous bone microdamage in the proximal femur: influence of age and osteoarthritis on damage morphology and regional distribution

138

Cancellous bone repair using bovine trabecular bone matrix particulates

139

Cancellous impaction and cortical strut allografting for revision shoulder arthroplasty: A case report

140

141

Cancer – Blame it all on viruses! Bladder tumours in cattle and sarcoids in horses may help us understand the relationship between some cancers and viruses

142

Cancer Risk in Pakistan Due to Natural Environmental Pollutants

143

Cancer “challenge” to limited-resource countries

144

Cancer ameliorating potential of Phyllanthus amarus: In vivo and in vitro studies against Aflatoxin B1 toxicity

145

Cancer among Farmers: A Meta-Analysis

146

Cancer and a Fatiguing Illness in Northern Nevada—A Causal Hypothesis

147

Cancer and aging: The molecular pathways

148

Cancer and Body Composition: An Association of Global Relevance

149

Cancer and comorbidity in older patients: A descriptive profile

150

Cancer and Complications of Peptic Ulcer in Type 2 Diabetes Mellitus patients at Wasit province, Iraq

151

cancer and covid-19: the synergistic burden on mental health status of patients with cancer

152

Cancer and Emotion; the Scope of Psycho‐Socio‐Oncology

153

Cancer and Emotion; The Scope of Psycho‐Socio‐Oncology: At the Time of Diagnosis

154

Cancer and Emotion; The Scope of Psycho-Socio-Oncology: At the Time of Treatment

155

Cancer and globalization

156

Cancer and HIV infection in Rwanda

157

Cancer and incontinence

158

Cancer and inflammation: A complex relationship

159

Cancer and its Treatment in Main Ancient Books of Islamic Iranian Traditional Medicine (7th to 14th Century AD)

160

Cancer and Low Levels of Plasma Cholesterol: The Relevance of Cholesterol Precursors and Products to Incidence of Cancer

161

Cancer and male infertility

162

Cancer and mutant DNA in blood plasma

163

Cancer and natural medicine: Textbook of basic science and clinical research: By John Boik, Oregon Medical Press, 1996

164

Cancer and Non-Cancer Risk of Arsenic in Drinking Water: A Case Study

165

Cancer and nonextensive statistics

166

Cancer and ovarian tissue cryopreservation

167

Cancer and psychosocial distress: frequent companions

168

Cancer and self-help: Bridging the troubled Waters of childhood illness : By Mark A. Chesler and Barbara K. Chesney. The University of Wisconsin Press, Madison, WI, 1995. 416 pp

169

Cancer and the human genome: no quick fix

170

Cancer and the meaning of work

171

Cancer and thromboembolic disease: how important is the risk of thrombosis?

172

Cancer and thromboembolic disease: pathogenic mechanisms

173

Cancer and thrombosis revisited

174

Cancer and venous thromboembolism

175

Cancer and Women’s Health

176

Cancer and wood-related occupational exposure in the Amazon region of Brazil

177

Cancer anorexia and cachexia

178

Cancer anorexia: a model for the understanding and treatment of secondary anorexia

179

Cancer anorexia: new pathogenic andtherapeutic insights

180

Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer

181

Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma

182

Cancer as a Complex Genetic Trait: Tumor Susceptibility in Humans and Mouse Models

183

Cancer as an Embryological Phenomenon and Its Developmental Pathways: A Hypothesis regarding the Contribution of the Noncanonical Wnt Pathway

184

Cancer associated with obstetric delivery: results of linkage with the California cancer registry

185

Cancer biology and necrotic changes in metastatic lymph nodes and survival of colon cancer patients

186

Cancer biology for the clinic and the lab

187

Cancer biomarker and neurotransmitters recognition by molecularly imprinted xero-gels

188

Cancer Biomarkers

189

Cancer biomarkers

190

Cancer biomarkers detection using 3D microstructured protein chip: Implementation of customized multiplex immunoassay

191

Cancer Biomarkers: Closer to Delivering on their Promise

192

Cancer Biopsy in Ancient Persian Medicine: Do or Not to Do!

193

Cancer bio-repository

194

Cancer bronchique localement évolué : qu’apporte la radiothérapie avec modulation d’intensité rotationnelle ?

195

Cancer bronchique localement évolué : qu’apporte la radiothérapie avec modulation d’intensité rotationnelle ?

196

Cancer bronchique non à petites cellules de l’apex pulmonaire et chimioradiothérapie de haute dose : expérience du centre hospitalier Lyon-Sud

197

Cancer bronchique non à petites cellules de l’apex pulmonaire et chimioradiothérapie de haute dose : expérience du centre hospitalier Lyon-Sud

198

Cancer bronchique non à petites cellules localement évolué : place de la chimioradiothérapie exclusive

199

Cancer bronchique non à petites cellules: mise au point en 1998

200

Cancer bronchique : le drainage lymphatique

201

Cancer burden and trends in the asian pacific RIM region

202

Cancer cachexia

203

Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation

204

Cancer Cachexia, Malnutrition, and Tissue Protein Turnover in Experimental Animals

205

Cancer Cachexia, Malnutrition, and Tissue Protein Turnover in Experimental Animals

206

Cancer cachexia: Measured and predicted resting energy expenditures for nutritional needs evaluation

207

Cancer cachexia: Metabolic alterations and clinical manifestations

208

Cancer Cancer vaccines: a road map for the next decade

209

Cancer care during the natural disasters, the lessons learned from Kermanshah Earthquake in 2017

210

Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: Evidentiary base and recommendations

211

Cancer cell detection in tissue sections using AFM

212

Cancer cell dissemination during curative surgery for colorectal liver metastases

213

Cancer Cell Dynamics in Presence of Telomerase Inhibitors: Analysis of In Vitro Data

214

Cancer Cell Invasion: Treatment and Monitoring Opportunities in Nanomedicine

215

Cancer Cell Metabolism: Warburg and Beyond

216

Cancer Cell progression

217

Cancer Cell Separation Using Passive Mechanisms: a Review

218

Cancer cell separator using size-dependent filtration in microfluidic chip

219

Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs

220

Cancer cells isolated from malignant pleural and peritoneal effusions inhibit phospholipase A2 activity in human polymorphonuclear leukocytes

221

Cancer Cells Release a Covalent Complex Containing Disulfide-Linked Domains from Urinary Plasminogen Activator, Neural Cell Adhesion Molecule, and Haptoglobin α and β Chains

222

Cancer Cells Treated by Clusters of Copper Oxide Doped Calcium Silicate

223

Cancer chemoprevention by dietary chlorophylls: A 12,000-animal dose–dose matrix biomarker and tumor study

224

Cancer chemoprevention with garlic and its constituents

225

Cancer Chemoprevention. Vol. 2: Strategies for Cancer Chemoprevention.G.J. Kellof, E.T. Hawk and C.C. Sigman, Editors, Humana Press, Totowa (2005).

226

Cancer Chemoprevention. Volume I. Promising Cancer Chemopreventive Agents.G.J. Kelloff, E. T. Hawk and C.C. Sigman, Editors, P. Humana Press, Totowa (2004)

227

Cancer chemoprevention: A radical perspective

228

Cancer chemopreventive activity of 3,5,6,7,8,3′,4′-heptamethoxyflavone from the peel of citrus plants

229

Cancer chemopreventive activity of 3β-methoxyserrat-14-en-21β-ol and several serratane analogs on two-stage mouse skin carcinogenesis

230

Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

231

Cancer chemopreventive activity of acridone alkaloids on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

232

Cancer chemopreventive activity of an iridoid glycoside, 8-acetylharpagide, from Ajuga decumbens

233

Cancer chemopreventive activity of carotenoids in the fruits of red paprika Capsicum annuum L.

234

Cancer chemopreventive activity of euglobal-G1 from leaves of Eucalyptus grandis

235

Cancer chemopreventive activity of flavanones on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

236

Cancer chemopreventive activity of majonoside-R2 from Vietnamese ginseng, Panax vietnamensis

237

Cancer chemopreventive activity of naphthoquinones and their analogs from Avicennia plants

238

Cancer chemopreventive activity of phenylpropanoid esters of sucrose, vanicoside B and lapathoside A, from Polygonum lapathifolium

239

Cancer chemopreventive activity of phenylpropanoids and phytoquinoids from Illicium plants

240

Cancer chemopreventive activity of serratane-type triterpenoids on two-stage mouse skin carcinogenesis

241

Cancer chemopreventive activity of synthetic colorants used in foods, pharmaceuticals and cosmetic preparations

242

Cancer chemopreventive agents, 4-phenylcoumarins from Calophyllum inophyllum

243

Cancer chemopreventive agents, labdane diterpenoids from the stem bark of Thuja standishii (Gord.) Carr

244

Cancer chemopreventive agents, serratane-type triterpenoids from Picea jezoensis

245

Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives

246

Cancer chemopreventive effect of dietary Zataria multiflora essential oils

247

Cancer chemopreventive effect of orally administrated lupane-type triterpenoid on ultraviolet light B induced photocarcinogenesis of hairless mouse

248

Cancer chemopreventive effect of quassinoid derivatives. Introduction of side chain to shinjulactone C for enhancement of inhibitory effect on Epstein–Barr virus activation

249

Cancer chemopreventive effects of constituents of Caesalpinia ferrea and related compounds

250

Cancer chemopreventive effects of oral feeding α-tocopherol on ultraviolet light B induced photocarcinogenesis of hairless mouse

251

Cancer chemopreventive effects of Pinus Maritima bark extract on ultraviolet radiation and ultraviolet radiation-7,12,dimethylbenz(a)anthracene induced skin carcinogenesis of hairless mice

252

Cancer chemopreventive effects of polyunsaturated fatty acids

253

Cancer Chemo-Preventive Effects of Red Propolis: a System Biology Approach

254

Cancer chemopreventive oltipraz generates superoxide anion radical

255

Cancer Chemoprotection by Oltipraz: Experimental and Clinical Considerations

256

Cancer chemotherapy – ribonucleases to the rescue Review Article

257

Cancer Chemotherapy and Biotherapy

258

Cancer chemotherapy in the older cancer patient

259

Cancer chemotherapy optimization under evolving drug resistance Original Research Article

260

Cancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogs

261

Cancer chemotherapy, biodiversity, public and private property: the case of the anti-cancer drug Taxol

262

Cancer chemotherapy: A SN-38 (7-Ethyl-10-hydroxycamptothecin) glucuronide prodrug for treatment by a PMT (Prodrug monoTherapy) strategy

263

Cancer chez le sujet âgé : place du dépistage gériatrique dans la décision thérapeutique

264

Cancer chez le sujet âgé : place du dépistage gériatrique dans la décision thérapeutique

265

Cancer Classification in Microarray Data using a Hybrid Selective Independent Component Analysis and υ‑Support Vector Machine Algorithm

266

Cancer Classification with a Cost-Sensitive Naive Bayes Stacking Ensemble

267

Cancer Control at the Workplace: The Working Well Trial

268

Cancer Control strategy in the world, a review article

269

Cancer control: a reminder of the need for a balanced approach between prevention and treatment

270

Cancer cutané et xéroderma pigmentosum

271

Cancer cutané et xéroderma pigmentosum

272

Cancer de l’endomètre de stade I

273

Cancer de l’estomac : doses et volumes-cibles

274

Cancer de l’estomac. Le point thérapeutique en 2008

275

Cancer de la langue : expérience de l’Institut national d’oncologie de Rabat, à propos de 60 cas

276

Cancer de la langue : expérience de l’Institut national d’oncologie de Rabat, à propos de 60 cas

277

Cancer de la prostate

278

Cancer de la prostate 2010. Innovations thérapeutiques

279

Cancer de la prostate chez l’homme de moins de 50 ans : à propos de 26 cas

280

Cancer de la prostate chez l’homme de moins de 50 ans : à propos de 26 cas

281

Cancer de la prostate localisé et radiothérapie conformationnelle avec modulation d’intensité : quels sont les paramètres dosimétriques les plus pertinents pour prédire la toxicité digestive aiguë ?

282

Cancer de la prostate localisé et radiothérapie conformationnelle avec modulation d’intensité : quels sont les paramètres dosimétriques les plus pertinents pour prédire la toxicité digestive aiguë ?

283

Cancer de la prostate localisé, à risque intermédiaire ou élevé, dont le traitement a été une radiothérapie externe et incluant une curiethérapie de haut débit de dose : expérience du pôle régional de cancérologie de Poitou-Charentes

284

Cancer de la prostate localisé, à risque intermédiaire ou élevé, dont le traitement a été une radiothérapie externe et incluant une curiethérapie de haut débit de dose : expérience du pôle régional de cancérologie de Poitou-Charentes

285

Cancer de la thyroïde après exposition aux rayonnements ionisants

286

Cancer de lʹœsophage : répercussion des thérapeutiques néoadjuvantes sur la morbidité et la mortalité opératoire

287

Cancer de prostate et RCMI guidée par l’image : absence de corrélation entre paramètres dose/volume des organes à risque et toxicité tardive

288

Cancer de prostate et RCMI guidée par l’image : absence de corrélation entre paramètres dose/volume des organes à risque et toxicité tardive

289

Cancer de prostate localisé. Que dire au patient ?

290

Cancer de prostate : doses et volumes cibles

291

Cancer death epidemics in United States Black males: Evaluating courses, causation, and cures

292

CANCER DEATH RATES AND BACKGROUND RADIATION

293

Cancer detection and mammogram volume of radiologists in a population-based screening programme

294

Cancer detection from textual data using a combination of machine learning approach

295

Cancer Detection Using Aritifical Neural Network and Support Vector Machine: A Comparative Study

296

Cancer Development and Electromagnetic Fields in Near Future

297

Cancer diagnosis by autofluorescence of blood components

298

Cancer Diagnosis Disclosure: What is the Right Thing to Do?

299

Cancer Diagnosis in Endoscopic Images using Discrete Wavelet Transform

300

Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study

301

Cancer Disclosure in Iran: Attitude of Patients and Their Families

302

Cancer disclosure in Japan: Historical comparisons, current practices

303

Cancer distress screening: Needs, models, and methods

304

Cancer dose–response assessment for acrylonitrile based upon rodent brain tumor incidence: Use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity

305

Cancer driver mutations in protein kinase genes

306

Cancer du canal anal : expérience de l’Institut national d’oncologie de Rabat, à propos de 110 cas

307

Cancer du canal anal : expérience de l’Institut national d’oncologie de Rabat, à propos de 110 cas

308

Cancer du cavum au centre tunisien : à propos de 525 cas

309

Cancer du cavum au centre tunisien : à propos de 525 cas

310

Cancer du cavum chez le sujet jeune

311

Cancer du cavum chez le sujet jeune

312

Cancer du cavum chez les sujets âgés : expérience d’un centre tunisien

313

Cancer du cavum chez les sujets âgés : expérience d’un centre tunisien

314

Cancer du cavum dans l’ouest algérien : à propos de 578 cas traités à Oran, Algérie

315

Cancer du cavum dans l’ouest algérien : à propos de 578 cas traités à Oran, Algérie

316

Cancer du cavum dans la région de Marrakech. Expérience du service d’oncologie du centre hospitalier universitaire Mohammed-VI de Marrakech

317

Cancer du cavum dans la région de Marrakech. Expérience du service d’oncologie du centre hospitalier universitaire Mohammed-VI de Marrakech

318

Cancer du cavum dans le centre tunisien : facteurs pronostiques

319

Cancer du cavum dans le centre tunisien : facteurs pronostiques

320

Cancer du cavum du sujet âgé

321

Cancer du cavum du sujet âgé

322

Cancer du cavum et syndromes paranéoplasiques

323

Cancer du cavum et syndromes paranéoplasiques

324

Cancer du col utérin

325

Cancer du col utérin chez la femme jeune : à propos de 96 cas au Centre d’oncologie du CHU Ibn Rochd de Casablanca

326

Cancer du col utérin chez la femme jeune : à propos de 96 cas au Centre d’oncologie du CHU Ibn Rochd de Casablanca

327

Cancer du col utérin stades IB et II opérable : comparaison rétrospective entre curiethérapie utérovaginale préopératoire et chirurgie première suivies d’une radiothérapie

328

Cancer du col utérin : expérience du Maroc, à propos de 696 cas

329

Cancer du col utérin : expérience du Maroc, à propos de 696 cas

330

Cancer du larynx chez le sujet âgé

331

Cancer du larynx chez le sujet âgé

332

Cancer du larynx : expérience de l’institut national d’oncologie de Rabat, à propos de 404 cas

333

Cancer du larynx : expérience de l’institut national d’oncologie de Rabat, à propos de 404 cas

334

Cancer du nasopharynx chez l’enfant et l’adolescent : expérience du service de radiothérapie et d’oncologie Ibn-Rochd de Casablanca

335

Cancer du nasopharynx chez l’enfant et l’adolescent : expérience du service de radiothérapie et d’oncologie Ibn-Rochd de Casablanca

336

Cancer du nasopharynx dans l’Ouest algérien : résultats à long terme et facteurs pronostiques dans une cohorte de 200 cas

337

Cancer du nasopharynx dans l’Ouest algérien : résultats à long terme et facteurs pronostiques dans une cohorte de 200 cas

338

Cancer du pancréas localement évolué non resécable : chimioradiothérapie d’induction suivie de chimiothérapie par gemcitabine contre chimiothérapie exclusive par gemcitabine : résultats définitifs de l’étude de phase III 2000–2001de la FFCD et de la SFRO

339

Cancer du rectum avec métastases synchrone

340

Cancer du rectum avec métastases synchrone

341

Cancer du rectum chez le sujet de moins de 40 ans

342

Cancer du rectum chez le sujet de moins de 40 ans

343

Cancer du rectum localement évolué : place du boost tumoral en chimioradiothérapie concomitante préopératoire, étude rétrospective portant sur 75 cas

344

Cancer du rectum localement évolué : place du boost tumoral en chimioradiothérapie concomitante préopératoire, étude rétrospective portant sur 75 cas

345

Cancer du rectum : volumes cibles de la radiothérapie préopératoire

346

347

Cancer du sein bilatéral après maladie de Hodgkin. Particularités clinico-histologiques et possibilités thérapeutiques: analyse de 13 cas

348

Cancer du sein chez la femme âgée

349

Cancer du sein chez la femme âgée

350

Cancer du sein chez la femme âgée de plus de 70 ans : expérience de l’Institut national d’oncologie de Rabat

351

Cancer du sein chez la femme âgée de plus de 70 ans : expérience de l’Institut national d’oncologie de Rabat

352

Cancer du sein chez la femme de moins de 40 ans dans la région de Marrakech

353

Cancer du sein chez la femme de moins de 40 ans dans la région de Marrakech

354

Cancer du sein chez la femme jeune au Maroc

355

Cancer du sein chez la personne âgée : place de la radiothérapie ?

356

Cancer du sein chez la personne âgée : place de la radiothérapie ?

357

Cancer du sein d’emblée métastatique : impact de l’irradiation locorégionale exclusive sur la survie globale

358

Cancer du sein d’emblée métastatique : impact de l’irradiation locorégionale exclusive sur la survie globale

359

Cancer du sein de la femme de moins de 35 ans

360

Cancer du sein de la femme de moins de 35 ans

361

Cancer du sein et radiothérapie peropératoire par électrons : revue des 100 premières patientes traitées à l’institut Jules-Bordet

362

Cancer du sein et radiothérapie peropératoire par électrons : revue des 100 premières patientes traitées à l’institut Jules-Bordet

363

Cancer du sein et ultrasons : de l’imagerie au traitement des cancers

364

Cancer du sein et ultrasons : de l’imagerie au traitement des cancers

365

Cancer du sein inflammatoire au centre hospitalier universitaire Hassan-II de Fès : à propos de 41 cas

366

Cancer du sein inflammatoire au centre hospitalier universitaire Hassan-II de Fès : à propos de 41 cas

367

Cancer du sein localement évolué non inflammatoire traité par association de chimiothérapie et de radiothérapie à dose préopératoire : réactualisation des résultats d’une série de 120 patientes

368

Cancer du sein métastatiques : intérêt du CA 15-3

369

Cancer du sein métastatiques : intérêt du CA 15-3

370

Cancer du sein négligé et localement évolué : quelle réalité ? Réflexion à propos de deux cas sur l’optimisation de la prise en charge multidisciplinaire

371

Cancer du sein secondaire chez l’homme après traitement pour maladie de Hodgkin. À propos d’un cas et revue de la littérature

372

Cancer du sein traité exclusivement par l’association d’une irradiation externe et d’une curiethérapie exclusive : résultats à long terme

373

Cancer du sein : comparaison dosimétrique entre la technique des filtres en coin et celle « champ dans le champ »

374

Cancer du sein : comparaison dosimétrique entre la technique des filtres en coin et celle « champ dans le champ »

375

Cancer du sein. Questions et réponses au quotidien, J Saglier, EC Antoine. Masson, New York (1996), 125

376

Cancer du canal anal : comparaison dosimétrique entre radiothérapie trimensionnelle classique et par modulation d’intensité

377

Cancer du canal anal : comparaison dosimétrique entre radiothérapie trimensionnelle classique et par modulation d’intensité

378

Cancer education among primary care physicians in an underserved community

379

Cancer epidemiology and trends in Sistan and Baluchestan province, Iran

380

Cancer Epidemiology in Lebanon

381

Cancer Epidemiology in Radiation Oncology: An Institutional Experience From North India During 2016-2022

382

Cancer Epidemiology: The International Journal of Cancer Epidemiology, Detection and Prevention

383

Cancer epigenetics as biomarkers of clinical significance

384

Cancer epigenetics is no Mickey Mouse

385

Cancer epigenetics is no Mickey Mouse

386

Cancer Epigenetics: From Mechanism to Therapy

387

CANCER ESOPHAGUS: AN AUDIT OF CURRENT MANAGEMENT FOR YEMENI PATIENTS

388

Cancer Events After Acute or Chronic Exposure to Sulfur Mustard: A Review of the Literature

389

Cancer experts square up for European funds

390

Cancer familiarity status in patients with early brest cancer: Our experience

391

Cancer fatalism among african-americans: A review of the literature

392

Cancer Feature Selection and Classification Using a Binary Quantum-Behaved Particle Swarm Optimization and Support Vector Machine

393

Cancer gene may move quickly into skin clinics

394

Cancer gene therapy targeting cellular apoptosis machinery

395

Cancer genes and molecular oncology in the clinic

396

Cancer gene-therapy: clinical trials

397

Cancer Genetics and Cytogenetics

398

Cancer Genetics and Epigenetics: Two Sides of the Same Coin?

399

Cancer genetics and genomics of human FOX family genes

400

Cancer Genetics and the Cardiotoxicity of the Therapeutics

401

Cancer genome sequencing: Understanding malignancy as a disease of the genome, its conformation, and its evolution

402

Cancer Genomes Evolve by Pulverizing Single Chromosomes

403

Cancer genomics

404

Cancer Genomics: The Road Ahead

405

Cancer groups meet in Edinburgh

406

cancer has an independent association with death in hospitalized patients with covid-19: a single-center study in iran

407

Cancer hazard identification and qualitative risk assessment

408

Cancer heterogeneity and “The Struggle for Existence”: Diagnostic and analytical challenges

409

Cancer hopes and setbacks

410

Cancer immunomics: Using autoantibody signatures in the early detection of prostate cancer

411

Cancer immunoprevention: tracking down persistent tumor antigens

412

Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

413

Cancer immunotherapy – broader considerations

414

Cancer Immunotherapy Using Microfluidic Systems

415

Cancer immunotherapy, mathematical modeling and optimal control

416

Cancer immunotherapy: novel strategies and clinical experiences

417

Cancer immunotherapy: simply cell biology?

418

Cancer immunotherapyʹs renaissance

419

Cancer in home care: Unintended weight loss and ethical challenges. A cross-sectional study of older people at 11 sites in Europe

420

Cancer in Kenya: types and infection-attributable. Data from the adult population of two National referral hospitals (2008-2012)

421

Cancer in Korean War Navy Technicians: Mortality Survey after 40 Years

422

Cancer in Lebanon: An Epidemiological Review of the American University of Beirut Medical Center Tumor Registry (1983–1994)

423

Cancer in married couples: Higher or lower distress?

424

Cancer in Maysan: Mortality, Pattern, and Demographic Characteristics during the Last 4 Decades

425

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study Original Research Article

426

Cancer in patients on renal replacement therapy in Lombardy, Italy

427

Cancer in people with depression or anxiety: record-linkage study

428

Cancer in pregnancy: Gaps, challenges and solutions

429

Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study

430

Cancer in the mass print media: Fear, uncertainty and the medical model

431

Cancer in the older person

432

Cancer in the Sudan: An overview of the current status of knowledge on tumor patterns and risk factors Original Research Article

433

Cancer incidence among Danish Seventh-day Adventists and Baptists

434

Cancer incidence among Mormons and non-Mormons in Utah (United States) 1995–1999

435

Cancer incidence among pesticide applicators exposed to trifluralin in the Agricultural Health Study

436

Cancer incidence among refinery and petrochemical employees in Louisiana, 1983–1999

437

Cancer Incidence among the Elderly Population in the Northwest of Iran: A Population Based Study

438

Cancer incidence and asbestos in drinking water, Town of Woodstock, New York, 1980–1998

439

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism

440

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism

441

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study

442

Cancer Incidence and Mortality in Ardabil: Report of an Ongoing Population-Based Cancer Registry in Iran, 2004-2006

443

Cancer incidence and mortality in people aged less than 75 years: Changes in Australia over the period 1987–2007

444

Cancer Incidence and Prevalence in Isfahan: Application of Mortality Data to Estimates and Projects for the Period 2001-2015

445

Cancer Incidence and Trend Analysis in Shahroud, Iran, 2000 – 2010

446

Cancer Incidence around an Oil Refinery as an Example of a Small Area Study Based on Map Coordinates

447

Cancer incidence estimation at a district level without a national registry: A validation study for 24 cancer sites using French health insurance and registry data

448

Cancer incidence in a petrochemical industry area in Sweden Original Research Article

449

Cancer incidence in children conceived with assisted reproduction technology

450

Cancer incidence in Dutch Balkan veterans

451

Cancer incidence in ethnic German migrants from the Former Soviet Union in comparison to the host population

452

Cancer Incidence in Golestan Province: Report of an Ongoing Population-based Cancer Registry in Iran between 2004 and 2008

453

Cancer incidence in Jordan, 1996–2005

454

Cancer Incidence in Montana: Rates for American Indians Exceed Those for Whites Original Research Article

455

Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study

456

Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998

457

Cancer Incidence in South East of Iran: Results of a Population-Based Cancer Registry

458

Cancer Incidence in Tehran Metropolis: The First Report from the Tehran Population-Based Cancer Registry, 1998 – 2001

459

Cancer incidence in the USA could double by 2050, report predicts

460

Cancer incidence in women exposed to DES in utero

461

Cancer Incidence Rate in the Elderly Inhabitants of Tehran: Is there Really any Cluster?

462

Cancer incidence rate ratios of Turkish immigrants in Hamburg, Germany: A registry based study

463

Cancer Incidence Rates among Iranian immigrants in Sweden, a Population-Based Retrospective Cohort Study

464

Cancer Incidence, Mortality and Survival in Türkiye as of 2020

465

Cancer indifférencié du cavum type : états des lieux dans le service de radiothérapie du centre hospitalier universitaire d’Oran

466

Cancer indifférencié du cavum type : états des lieux dans le service de radiothérapie du centre hospitalier universitaire d’Oran

467

Cancer indifférencié du cavum : aspects épidémiologiques, cliniques et thérapeutiques

468

Cancer indifférencié du cavum : aspects épidémiologiques, cliniques et thérapeutiques

469

Cancer Induced Infertility and the Role of L-Carnitine: A Review for Possible Future Clinical Applications

470

Cancer informatics by prototype networks in mass spectrometry

471

Cancer Information Service-Initiated Outcalls to Promote Screening Mammography among Low-Income and Minority Women: Design and Feasibility Testing, ,

472

Cancer initiation by fumonisin B1 in rat liver – role of cell proliferation

473

Cancer Invasion and the Microenvironment: Plasticity and Reciprocity

474

Cancer Is to Embryology as Mutation Is to Genetics: Hypothesis of the Cancer as Embryological Phenomenon

475

Cancer letters special issue hepatocellular carcinoma featuring the guest editors

476

Cancer Letters special issue inflammation and gastrointestinal and liver cancers featuring the guest editor

477

Cancer Letters. Featuring the guest editors: Wael M. ElShamy and Roy J. Duhé

478

Cancer magnitude, challenges and control in the Eastern Mediterranean Region

479

Cancer marker detection in human serum with a point-of-care low-cost system

480

Cancer metabolism and the dynamics of metastasis

481

Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy

482

Cancer Metabolism: Is Glutamine Sweeter than Glucose?

483

Cancer metastasis at a glance: A brief view of Breast Cancer Brain Metastasis

484

Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells

485

Cancer mode of action, weight of evidence, and proposed cancer reference value for hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)

486

Cancer Modeling and Simulation, L. Preziosi (Ed.). Chapman and Hall/CRC (2003)

487

Cancer Modeling in the Modern Era: Progress and Challenges

488

Cancer Molecular Analysis Project: Weaving a rich cancer research tapestry

489

Cancer molecules reveal their mechanisms

490

Cancer morbidity in subjects occupationally exposed to high frequency (radiofrequency and microwave) electromagnetic radiation

491

Cancer mortality among agricultural workers from Serrana Region, state of Rio de Janeiro, Brazil

492

Cancer mortality among workers in formaldehyde industries

493

Cancer mortality among workers in the meat department of supermarkets : E. S. Johnson, Occupational and Environmental Medicine, 51(8), 541–547

494

Cancer mortality and occupational exposure to aromatic amines and inhalable aerosols in rubber tire manufacturing in Poland

495

Cancer mortality and offset printing

496

Cancer mortality and prevention in the European Union

497

Cancer mortality around French nuclear sites

498

Cancer mortality in Basrah: a household survey results

499

Cancer nanomedicine: A review on approaches and applications towards targeted drug delivery

500

Cancer nanomedicines targeting tumor extracellular pH

501

Cancer nanomedicines: So many papers and so few drugs!

502

Cancer nanotechnology

503

Cancer nanotechnology

504

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

505

Cancer Nursing: Care in Context: Jessica Corner, Christopher Bailey (Eds.); Blackwell Science, Oxford, 2001, ISBN 0-632-03998-1

506

Cancer Occurrence in Fars Province, Southern Iran

507

Cancer Occurrence in the Elderly: Agreement between Three Major Data Sources

508

Cancer of children in Basrah-Iraq: Person and time characteristics

509

Cancer of Male Urethra: Case Series and Review of Literature

510

Cancer of the breast, fifth edition.: William L. Donegan and John S. Spratt publisher: Saunders, Philadelphia, pages: 1,025. price: $179.00

511

Cancer of the breast: Is radiation therapy curative

512

Cancer of the Colon and Rectum in California: Trends in Incidence by Race/Ethnicity, Stage, and Subsite,

513

Cancer of the esophagus: histopathological sub-types in northern Uganda

514

Cancer of the gastric cardia

515

Cancer of the gastrointestinal tract results in a restricted T-cell repertoire dependent upon tumor differentiation

516

Cancer of the larynx in females

517

Cancer of the larynx in Hong Kong: a clinico-pathological study

518

Cancer of the pharynx and larynx

519

Cancer of the rectum—palliative endoscopic treatment

520

Cancer of unknown primary origin: a decade of experience in a community-based hospital

521

Cancer of unknown primary patients with midline nodal distribution: Midway between poor and favourable prognosis?

522

Cancer omics: From regulatory networks to clinical outcomes

523

Cancer onset and progression: A genome-wide, nonlinear dynamical systems perspective on onconetworks

524

Cancer pain relief achieved in mice with proenkephalin-expressing herpes vector

525

Cancer pain relief, 2nd Edn : WHO, Geneva. £11.90, ISBN 92 4 154482 1

526

Cancer Pain; Physical Factors affecting Pain Experience

527

Cancer paper retracted

528

Cancer patient advocacy: New opportunities for treatment advances

529

Cancer patient survival in Estonia 1995–2009: Time trends and data quality

530

Cancer patients and loneliness: A systematic review

531

Cancer patients desire for information: a study in a teaching hospita l in Saudi Arabia

532

Cancer patients overestimate survival chances

533

Cancer patients' satisfaction with communication and information given by nurses at teaching hospitals of Tehran, Iran

534

Cancer patientsʹ satisfaction with physicians: Princess Margaret hospital satisfaction with doctor questionnaire results

535

Cancer Patients Who Elect Euthanasia as an Option: An Argumentative Essay

536

Cancer Patients’ Challenges During COVID-19 Pandemic: An Approach to Decision-Making in Management and Policy-Making i

537

Cancer Patients’ Perceptions of Family Psychological Support: A Qualitative Study

538

Cancer Patients’ Perceptions of Family Psychological Support: A Qualitative Study

539

Cancer patients’ reluctance to discuss psychological distress with their physicians was not associated with underrecognition of depression by physicians: A preliminary study

540

Cancer pattern and survival in a rural district in South India

541

Cancer prevention

542

Cancer Prevention - Behavior Changes: The Short and the Long of It

543

Cancer prevention – the potential for diet to modulate molecular signalling

544

Cancer Prevention & Control Strategy: Resolution adopted by the 58th World Health Assembly, Geneva, May 25, 2005

545

Cancer Prevention Among Urban Southwestern American Indian Women: Comparison to Selected Year 2000 National Health Objectives

546

Cancer prevention by carotenoids

547

Cancer prevention by food factors through targeting signal transduction pathways,

548

Cancer Prevention by Protease Inhibitors

549

Cancer prevention by tocopherols and tea polyphenols

550

Cancer prevention in primary care: Predictors of patient counseling across four risk behaviors over 24 months

551

Cancer prevention in rural primary care: An academic-practice partnership

552

Cancer prevention studies: Past, present, and future directions

553

Cancer prevention studies—Past, present, and future directions

554

Cancer prevention trials and primary care physicians: Factors associated with recommending trial enrollment

555

Cancer Prevention: Chemoprevention vs Dietary Modifications

556

Cancer prevention: epidemiology and experiment

557

Cancer Prevention; Cancer Risk Management

558

Cancer Prevention; Emerging Infectious Diseases as Risk Factors, Iran Feature

559

Cancer preventive agents, Part 2: Synthesis and evaluation of 2-phenyl-4-quinolone and 9-oxo-9,10-dihydroacridine derivatives as novel antitumor promoters Original Research Article

560

Cancer preventive agents. Part 1: Chemopreventive potential of cimigenol, cimigenol-3,15-dione, and related compounds Original Research Article

561

Cancer preventive effects of flavonoids—a review

562

Cancer preventive potential of trichothecenes from Trichothecium roseum Original Research Article

563

Cancer preventive properties of ginger: A brief review

564

Cancer preventive screening: A cross-border comparison of United States and Canadian Chinese women

565

Cancer procoagulant and blood platelet activation

566

Cancer progression and p53

567

Cancer progression is associated with increased expression of basement membrane proteins in three-dimensional in vitro models of human oral cancer

568

Cancer prostatique localisé traité par irradiation conformationnelle avec modulation dʹintensité avec ou sans repositionnement échographique : la dose reçue est-elle équivalente à la dose prescrite ?

569

Cancer prostatique localisé traité par irradiation conformationnelle avec modulation dʹintensité avec ou sans repositionnement échographique : la dose reçue est-elle équivalente à la dose prescrite ?

570

Cancer proteomics: from signaling networks to tumor markers

571

Cancer proteomics: from signaling networks to tumor markers

572

Cancer radio induit par la radiothérapie des carcinomes nasopharyngés : à propos de huit cas

573

Cancer radio induit par la radiothérapie des carcinomes nasopharyngés : à propos de huit cas

574

Cancer rectocolique chez le sujet jeune

575

Cancer rectocolique chez le sujet jeune

576

Cancer Registry in Iran: a Brief Overview

577

Cancer related factors do not explain the quality of life scores for childhood cancer survivors analysed with two different generic HRQL instruments

578

Cancer Related Fears in Iranian Patients, a Survey from South East of Iran

579

Cancer related inflammation: The macrophage connection

580

Cancer research priorities for early diagnosis in Iran: Analyses based on Multiple-Attribute Decision Making Model

581

Cancer Research Studies in Native Hawaiians and Pacific Islanders

582

Cancer Research UK looks to NCI forsuccess

583

Cancer researchers get down to arrays at AACR

584

Cancer Resection on the Residual Lung After Pneumonectomy for Bronchogenic Carcinoma

585

Cancer responds better to combined treatments

586

Cancer risk above 1 Gy and the impact for space radiation protection Original Research Article

587

Cancer risk after a hospital discharge diagnosis of endometriosis, , ,

588

Cancer risk after non-melanoma skin cancer

589

Cancer risk among patients with multiple sclerosis: A cohort study in Isfahan, Iran

590

Cancer risk analysis by fuzzy logic approach and performance status of the model

591

Cancer Risk Analysis of Benzene and Ethyl Benzene in Painters

592

Cancer risk and all-cause mortality among Norwegian military United Nations peacekeepers deployed to Kosovo between 1999 and 2011

593

Cancer risk and Barrett’s esophagus

594

Cancer Risk Assessment and the Genetic Counseling Process: Using Hereditary Breast and Ovarian Cancer as an Example

595

Cancer Risk Assessment Benzene, Toluene, Ethylbenzene and Xylene (BTEX) in the Production of Insulation Bituminous

596

Cancer Risk Assessment due to Accidental Exposure inside Neutron Laboratories using BEIR VII Model

597

Cancer risk assessment for Tehran research reactor and radioisotope laboratory with CAP88-PC code (Gaussian plume model)

598

Cancer Risk Assessment for Workers Exposed to Pollution Source, a Petrochemical Company, Iran

599

Cancer Risk Assessment From Multi-Exposure to Chloroform in Drinking Water of Ilam City, Iran

600

Cancer risk assessment from trihalomethanes in drinking water

601

Cancer Risk Assessment in Welder's Under Different Exposure Scenarios

602

Cancer risk assessment using blood dioxin levels and daily dietary TEQ intake in general populations of industrial and non-industrial countries

603

Cancer Risk Assessment: Evolution of the Process

604

Cancer Risk Assessment: Quality and Impact of the Family History Interview

605

Cancer Risk at Sites Other than the Breast Following Augmentation Mammoplasty

606

Cancer risk due to contamination: Consideration from market basket survey in Qatar

607

Cancer risk factors among men of diverse Hispanic or Latino origins

608

Cancer risk in endoscopically unresectable colon polyps

609

Cancer risk in hypertensive patients treated with calcium channel blockers

610

Cancer risk in menopausal women

611

Cancer risk in patients on dialysis

612

Cancer risk in patients on dialysis and after renal transplantation Original Research Article

613

Cancer risk in patients with monoclonal gammopathy of undetermined significance

614

Cancer risk models and preselection for screening

615

Cancer risk, hypertension, and antihypertensive medication

616

Cancer risks associated with the diagnosis of infertility

617

Cancer risks in children with congenital malformations in the nervous and circulatory system—A population based cohort study

618

Cancer screening among Latino subgroups in the United States

619

Cancer screening among older women in a culturally insular community

620

Cancer Screening Among the Overweight and Obese in Canada Original Research Article

621

Cancer screening and prevention practices of inner-city physicians

622

Cancer screening behaviors among smokers and non-smokers

623

Cancer Screening Benefits Maximization Using Markov Decision Process Models: A Systematic Review

624

Cancer screening estimates for U.S. metropolitan areas Original Research Article

625

Cancer Screening Guidelines: A Rapid Review

626

Cancer screening in end-stage renal disease

627

Cancer Screening in HMOs:: Program Development and Evaluation

628

Cancer screening in the elderly

629

Cancer Screening in Women: Body Mass Index and Adherence to Physician Recommendations Original Research Article

630

Cancer screening knowledge, attitudes, and behaviors among culturally Deaf adults: Implications for informed decision making

631

Cancer Screening Practice among Iranian Middleaged Women

632

Cancer screening practices among cancer survivors Original Research Article

633

Cancer screening with whole-body F-fluorodeoxyglucose positron-emission tomography

634

Cancer Screening, Effective or Harmful?

635

Cancer Screening, Effective or Harmful?

636

Cancer Screening: Knowledge, Attitudes, and Practices among Healthcare Personnel

637

Cancer Screening: Should Cancer Screening be Essential Component of Primary Health Care in Developing Countries?

638

Cancer self remission and tumor stability – a stochastic approach

639

Cancer should be prioritised on WHO agenda

640

Cancer Statistics in I.R. Iran in 2020

641

Cancer statistics: Current diagnosis and treatment of pancreatic cancer in Shanghai, China

642

Cancer stem cell biomarkers: critical roles, challenges, clinical applications and perspectives in cancer therapy

643

Cancer stem cell dynamics in tumor progression and metastasis: Is the microenvironment to blame?

644

Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter

645

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma

646

Cancer stem cell markers in common cancers – therapeutic implications

647

Cancer stem cell, niche and EGFR decide tumor development and treatment response: A bio-computational simulation study

648

Cancer Stem Cell’s Potential Clinical Implications

649

Cancer Stem Cell’s Potential Clinical Implications

650

Cancer stem cells (CSCs): the blockage of metastatic and stemness properties by metal nanoparticles

651

Cancer Stem Cells and Oral Carcinogenesis; a Review Article

652

Cancer stem cells and telomerase as potential biomarkers in veterinary oncology

653

Cancer stem cells and tumor angiogenesis

654

Cancer stem cells as the engine of unstable tumor progression

655

Cancer stem cells CD133 and CD24 in colorectal cancers in Northern Iran

656

Cancer stem cells hypothesis and stem cells in head and neck cancers

657

Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective

658

Cancer stem cells in multiple myeloma

659

Cancer stem cells in urologic cancers

660

Cancer stem cells may drive growth of paediatric brain tumours

661

Cancer stem cells niche: A target for novel cancer therapeutics

662

Cancer stem cells sustaining the growth of mouse melanoma are not rare

663

Cancer stem cells, CD200 and immunoevasion

664

Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: Potential role of hypoxia

665

Cancer stem cells: A contentious hypothesis now moving forward

666

Cancer stem cells: Beyond Koch’s postulates

667

Cancer stem cells: emerging actors in both basic and clinical cancer research

668

Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty

669

Cancer stem cells: In the line of fire

670

Cancer stem cells: New therapeutic targets?

671

Cancer stem cells: potential target for bioactive food components

672

Cancer stem cells: Recent developments and future prospects

673

Cancer Stem Cells: Targets for treatment of malignancies to overcome drug resistance

674

Cancer stem cells: Toward novel anti-cancer therapies?

675

Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway

676

Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer

677

Cancer stromal targeting (CAST) therapy

678

Cancer surgery in the elderly—overall conclusions

679

Cancer surgery: the last 25 years

680

Cancer surveillance in Italian army peacekeeping troops deployed in Bosnia and Kosovo, 1996–2007: Preliminary results

681

Cancer survival

682

Cancer survival

683

Cancer survival as a function of age at diagnosis: A study of the Surveillance, Epidemiology and End Results database

684

Cancer survival classification using integrated data sets and intermediate information

685

Cancer survival in New Zealand: Ethnic, social and geographical inequalities

686

Cancer survival in patients with HIV/AIDS in the era of highly active antiretroviral therapy in Taiwan: A population-based cohort study

687

Cancer survival is no lottery

688

Cancer survival rates and GDP expenditure on health: a comparison of England and Wales and the USA, Denmark, Netherlands, Finland, France, Germany, Italy, Spain and Switzerland in the 1990s

689

Cancer Susceptibility and the Functions of BRCA1 and BRCA2

690

Cancer targeting strategies in nanomedicine: Design and application of chitosan nanoparticles

691

Cancer Terminologies Used in the Medieval Texts to the Early Modern Iranian Traditional Medicine (ITM)

692

Cancer theranostics: the rise of targeted magnetic nanoparticles

693

Cancer therapeutics in yeast

694

Cancer therapy with particle accelerators Original Research Article

695

Cancer therapy with phytochemicals: evidence from clinical studies

696

Cancer therapy: can the challenge be MET?

697

Cancer treatment by telomerase inhibitors: predictions by a kinetic model

698

Cancer treatment comes to age: from one-size-fits-all to next-generation sequencing (NGS) technologies

699

CANCER TREATMENT -OBJECTIVES AND QUALITY OF LIFE ISSUES

700

Cancer treatment reviews welcomes submission of the Cochrane Reviews

701

Cancer Treatment with the Alternative Herbal Medicine HUMA: Two Case Reports

702

Cancer treatment: the last 25 years

703

Cancer treatment-induced bone loss in premenopausal women: A need for therapeutic intervention?

704

Cancer Trends and the Importance of Prevention

705

Cancer trends in a province of Southwest of Iran, 2003–2016

706

Cancer tribe gathers

707

Cancer truth disclosure by Lebanese doctors

708

Cancer Tumor antigens

709

Cancer Turning in on death programs

710

Cancer types in dermatomyositis and polymyositis

711

Cancer types in dermatomyositis and polymyositis

712

Cancer Types in Pathological Samples Referred to Educational Hospitals in Birjand During the Past Three Years (2011 - 2013)

713

Cancer Types in Pathological Samples Referred to Educational Hospitals in Birjand During the Past Three Years (2011 - 2013).

714

Cancer Types in Pathological Samples Referred to Educational Hospitals in Birjand During the Past Three Years (2011-2013)

715

Cancer Types in Pathological Samples Referred to Educational Hospitals in Birjand During the Past Three Years (2011-2013)

716

Cancer vaccination progress

717

Cancer vaccines: a step towards prevention and treatment of cancer

718

Cancer vaccines: Harnessing the potential of anti-tumor immunity

719

Cancer Vulnerabilities Unveiled by Genomic Loss

720

Cancer warnings for West Bengalis drinking arsenic-contaminated water

721

Cancer Wars: How politics shapes what we know and donʹt know about cancer : Robert N. Proctor Basic Books, New York (1995) 356pp, indexes ISBN 0 465 02756 3 $25 hardback

722

Cancer wasting and quality of life react to early individualized nutritional counselling!

723

Cancer, A Big Monster, Which Should Be Defeated / The Editorial

724

Cancer, cancer cachexia, and diet: lessons from clinical research

725

Cancer, Chemotherapy, and Cor Pulmonale

726

Cancer, dépression et anxiété

727

Cancer, Somatic Mutation and Stem Cells

728

Cancer/radiothérapie

729

Cancer/testis antigens: A prospective reagent as diagnostic and immunotherapeutic targets for squamous cell carcinoma of the head and neck

730

Cancer/Testis genes in relation to sperm biology and function

731

Cancer: #1 The relationship of reproductive and body composition factors on the stage of cancer at diagnosis among non-hispanic white and hispanic postmenopausal breast cancer cases

732

Cancer: a lesson for us all

733

Cancer: A Systems Biology disease

734

Cancer: care or cure?

735

Cancer: Disease Caused by Alteration of Genes

736

Cancer: Editorial overview

737

Cancer: Editorial overview

738

Cancer: impact of nutrition intervention outcome—nutrition issues for patients

739

Cancer: Some genetic considerations

740

Cancer: Surviving on the edge

741

Cancer: The Future features in Iran

742

Cancer—a call for papers

743

Cancer—a call for papers

744

Cancer—a degenerative disorder?

745

Cancer-aociated Nummular Lo of the Pigment Epithelium

746

Cancer-aociated retinopathy aociated with invaive thymoma

747

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner

748

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner

749

Cancer-associated genodermatoses and familial cancer syndromes with cutaneous manifestations

750

Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy

751

Cancer-associated immune-mediated syndromes: Pathogenic values and clinical implementation

752

Cancer-Associated Mutations in BRC Domains of BRCA2 Affect Homologous Recombination Induced by Rad51

753

Cancer-associated thrombosis

754

Cancer-causing karyotypes: chromosomal equilibria between destabilizing aneuploidy and stabilizing selection for oncogenic function

755

cancer-curative potential of novel coumarins from watermelon princess: a scenario of their isolation and activity

756

Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up

757

Cancerous Tissue Diagnosis by LIF Spectroscopy Derived From Body-Compatible Fluorophores

758

Cancer-Preventive Effects of Drinking Green Tea among a Japanese Population,

759

Cancer-preventive isothiocyanates: dichotomous modulators of oxidative stress

760

Cancer-Preventive Selenocompounds Induce a Specific Redox Modification of Cysteine-Rich Regions in Ca2+- Dependent Isoenzymes of Protein Kinase C

761

Cancer-registry data in Latvia

762

Cancer-related fatigue: Links with inflammation in cancer patients and survivors

763

Cancer-related fears: A significant psychological burden in cancer patients and their caregivers

764

Cancer-related knowledge, attitudes, and behaviors among Chamorros on Guam

765

Cancer-Related Self-Efficacy in Iranian Women With Breast Cancer

766

Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis

767

Cancer-risk benefits of clean fuel technology and policy: A statistical analysis

768

Cancers after Renal Transplantation: Multicenter Experience

769

Cancers bronchiques non à petites cellules avec oligométastases : prise en charge chirurgicale à visée curative

770

Cancers bronchiques non à petites cellules de stade I : radiothérapie tridimensionnelle et radiothérapie en conditions stéréotaxiques

771

Cancers bronchiques non à petites cellules de stade I : radiothérapie tridimensionnelle et radiothérapie en conditions stéréotaxiques

772

Cancers bronchiques non à petites cellules localement évolués : curiethérapie de haut débit de dose complémentaire dʹune radiothérapie externe à visée curative

773

Cancers bronchiques non à petites cellules : amélioration des chances de survie par la radiothérapie conformationnelle ?

774

Cancers bronchiques non à petites cellules : facteurs prédictifs de survenue de pneumopathie radique

775

Cancers bronchiques non à petites cellules : facteurs prédictifs de survenue de pneumopathie radique

776

Cancers bronchiques non à petites cellules : facteurs prédictifs de survenue de pneumopathie radique

777

Cancers bronchiques traités par irradiation tridimensionnelle : influence de la délinéation pulmonaire en mode automatique seul ou en mode automatique excluant le volume cible prévisionnel

778

Cancers bronchiques traités par irradiation tridimensionnelle : influence de la délinéation pulmonaire en mode automatique seul ou en mode automatique excluant le volume cible prévisionnel

779

Cancers bronchiques : la radiothérapie prophylactique des aires ganglionnaires a-t-elle encore une place ?

780

Cancers bronchopulmonaires chez le sujet jeune

781

Cancers bronchopulmonaires chez le sujet jeune

782

Cancers de l’amygdale : peut-on ne pas irradier les patients en situation de bonne réponse à la chimiothérapie d’induction ?

783

Cancers de l’amygdale : peut-on ne pas irradier les patients en situation de bonne réponse à la chimiothérapie d’induction ?

784

Cancers de la cavité buccale : à propos de 145 cas à l’institut Joliot-Curie de Dakar

785

Cancers de la cavité buccale : à propos de 145 cas à l’institut Joliot-Curie de Dakar

786

Cancers de la prostate

787

Cancers de la tête et du cou

788

Cancers de prostate : le traitement local par irradiation a-t-il un impact sur la survie ?

789

Cancers de prostate : quelle place pour la radiothérapie à visée curative chez les patients âgés ?

790

Cancers de prostate : quelles techniques de radiothérapie pour quelles tumeurs ? Enjeux éthiques et méthodologiques

791

Cancers de VADS

792

Cancers des voies aérodigestives supérieures : bénéfices cliniques de la radiothérapie conformationnelle et de la modulation d’intensité

793

Cancers des voies aérodigestives supérieures : le retour de la chimiothérapie néoadjuvante ?

794

Cancers du foie et des voies biliaires

795

Cancers du nasopharynx chez l’enfant et l’adolescent : aspects particuliers

796

Cancers du nasopharynx chez l’enfant et l’adolescent : aspects particuliers

797

Cancers du poumon non à petites cellules

798

Cancers du rectum : la chimioradiothérapie préopératoire, nouveau standard

799

Cancers du rectum : volumes cible de la radiothérapie, bases rationnelles

800

Cancers du sein après radiothérapie : facteurs de risque et proposition de définition du sein chez la jeune fille prépubère comme organe à risque

801

Cancers du sein après radiothérapie : facteurs de risque et proposition de définition du sein chez la jeune fille prépubère comme organe à risque

802

Cancers du sein de petit stade : la radiothérapie exclusive est-elle une option en cas de réponse clinique complète à la chimiothérapie néoadjuvante ?

803

Cancers du sein de petit stade : la radiothérapie exclusive est-elle une option en cas de réponse clinique complète à la chimiothérapie néoadjuvante ?

804

Cancers du sein de stade II-IIIA : la radiothérapie exclusive est-elle une option en cas de réponse clinique complète à la chimiothérapie néoadjuvante ?

805

Cancers du sein localement évolués (T3-T4b) avec curage ganglionnaire négatif (sans chimiothérapie néoadjuvante) : profil évolutif et facteurs pronostiques

806

Cancers du sein localement évolués (T3-T4b) avec curage ganglionnaire négatif (sans chimiothérapie néoadjuvante) : profil évolutif et facteurs pronostiques

807

Cancers du sein radio-induits présentant des caractéristiques anatomopathologiques agressives : étude rétrospective du comité de suivi à long terme de la Société française des cancers de l’enfant

808

Cancers du sein radio-induits présentant des caractéristiques anatomopathologiques agressives : étude rétrospective du comité de suivi à long terme de la Société française des cancers de l’enfant

809

Cancers du sein : comment associer l’hormonothérapie et la radiothérapie en situation adjuvante ?

810

Cancers of the blood from benzene

811

Cancers of the Brain and CNS: Global Patterns and Trends in Incidence

812

Cancers of the salivary gland: Workplace risks among women and men

813

Cancers of the Upper Gastro-intestinal Tract: A Review of Somatic Mutation Distributions

814

Cancers of Urinary System; Prevalence, Demographic

815

Cancers primitifs invasifs de la vulve : expérience de l’Institut national d’oncologie de Rabat

816

Cancers primitifs invasifs de la vulve : expérience de l’Institut national d’oncologie de Rabat

817

Cancers radio-induits: le point en 1997

818

Cancers rectocoliques chez le sujet de moins de 40 ans

819

Cancers secondaires ou seconds cancers ?

820

Cancers secondaires ou seconds cancers ?

821

Cancerʹs sweet tooth

822

Cancerʹs sweet tooth: the Janus effect of glucose metabolism in tumorigenesis

823

Cancers, Mainly Male, as Population Biomarkers for Breast Cancer Mortality

824

Cancer-specific chemoprevention and anti-metastatic potentials of Rheum emodi rhizome ethyl acetate extracts and identification of active principles through HPLC and GC-MS analysis

825

Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma

826

Cancْn following Copenhagen

827

Cancrinite and sodalite formation in the presence of cesium, potassium, magnesium, calcium and strontium in Hanford tank waste simulants

828

829

830

Cancrum oris and noma: some etymological and historical remarks

831

Cancrum oris: its incidence and treatment in Enugu, Nigeria

832

Cancun 2002: The role of nanomaterials in solar energy conversion

833

Cand1 Promotes Assembly of New SCF Complexes through Dynamic Exchange of F Box Proteins

834

Candelabra systems and designs

835

Candesartan and heart failure: the allure of CHARM

836

Candesartan Attenuates Ischemic Brain Edema and Protects the Blood–Brain Barrier Integrity from Ischemia/Reperfusion Injury in Rats

837

Candesartan cilexetil and renal hemodynamics in hypertensive patients

838

Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension

839

Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough

840

Candesartan improves myocardial damage in obese mice with viral myocarditis and induces cardiac adiponectin

841

Candesartan in the prevention of relapsing atrial fibrillation

842

CANDESARTAN TREATMENT RESTORES DIABETES-INDUCED CHANGES IN [CA2+]I TRANSIENTS OF CARDIOMYOCYTES

843

Candesartan-Based Therapy and Risk of Cancer in Patients With Systemic Hypertension (Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease [HIJ-CREATE] Substudy)

844

Candi Sungai Batu (Tapak SB1): Kearifan Tempatan dalam Teknologi Pembuatan Bata dan Seni Bina Candi

845

Candid “confessions” of an editor: prioritizing journal space when increased submissions have led to publication backlog

846

Candid candidate comments: The relationship between residency program selection factors and match list placements from ranked applicants

847

Candid covariance-free incremental principal component analysis

848

Candida Albicans Activated Splenocytes Promote Strong Immune Responses in a Murine Model of Breast Cancer

849

Candida albicans adherence on silicone elastomers: Effect of polymerisation duration and exposure to simulated saliva and nasal secretion

850

Candida albicans Adherence to Glass Ionomer Restorative Dental Material

851

Candida albicans and HTV-1 Infection

852

Candida albicans cell wall comprises a branched β-d-(1→6)-glucan with β-d-(1→3)-side chains Original Research Article

853

Candida albicans depress cardiovascular function of rabbit

854

Candida Albicans detection in pre-malignant and malignant lesions of the oral cavity

855

Candida albicans endophthalmitis after anabolic steroid abuse

856

Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production

857

Candida albicans mannan- and protein-induced humoral, cellular and cytokine responses in atopic dermatitis patients

858

Candida albicans Release Intracellular Bacteria When Treated With Amphotericin B

859

Candida albicans Structural and Secreted Proteins Modulate CD4/CD8 Ratio in Tumor Infiltrating Lymphocytes of Spontaneous Adenocarcinoma Bearing Mice

860

Candida albicans suppresses nitric oxide (NO) production by interferon-gamma (IFN - gamma) and lipopolysaccharide (LPS)-stimulated murine peritoneal macrophages

861

Candida albicansNucleoside-Diphosphate Kinase: Purification and Characterization

862

Candida antarctica lipase A and Pseudomonas stutzeri lipase as a pair of stereocomplementary enzymes for the resolution of 1,2-diarylethanols and 1,2-diarylethanamines

863

Candida antarctica Lipase B Immobilization Onto Hybrid Organic-inorganic Mesoporous Materials

864

Candida antarctica lipase B-catalyzed reactions of β-hydroxy esters: Competition of acylation and hydrolysis

865

Candida antarctica lipase B-catalyzed synthesis of acetamides using [BMIm(PF6)] as a reaction medium

866

Candida antarctica lipase B-catalyzed the unprecedented three-component Hantzsch-type reaction of aldehyde with acetamide and 1,3-dicarbonyl compounds in non-aqueous solvent

867

Candida antarctica lipases acting as versatile catalysts for the synthesis of enantiopure (R)- and (S)-1-(2-phenylthiazol-4-yl)ethanamines

868

Candida Antigen Titer Elevation and Mortality in Burn Patients

869

Candida auris and COVID-19: A health threatening combination

870

Candida auris emergence in the Himalayan foothills: First case report from Uttarakhand, India

871

Candida auris in a tertiary healthcare setting in south India: A case series

872

Candida auris: A New Emerging Fungal Monster

873

Candida auris: outbreak fungal pathogen in COVID-19 pandemic: a systematic review and meta-analysis

874

candida berkh. (1923) species and their important secreted aspartyl proteinases (sap) genes isolated from diabetic patients

875

Candida Bloodstream Infection: Changing Pattern of Occurrence and Antifungal Susceptibility over 10 Years in a Tertiary Care Saudi Hospital

876

Candida Carriage Rate and Growth Characteristics of Saliva in Diabetes Mellitus Patients: A Case-Control Study

877

Candida cloacae oxidation of long-chain fatty acids to dioic acids

878

Candida colonisation within a silicone tissue expander

879

Candida Colonization in Low Birth Weight and Very Low Birth Weight Infants in a Neonatal Intensive Care Unit

880

Candida colonization of the esophagus and gastric mucosa; a comparison of patients taking proton pump inhibitors and those taking histamine receptor antagonist drugs

881

Candida Colonization on the Denture of Diabeticand Non-diabetic Patients

882

Candida Colonization on the Denture of Diabeticand Non-diabetic Patients

883

Candida commensalism and virulence: the evolution of phenotypic plasticity

884

Candida dubliniensis: A rare cause of nail infection

885

Candida glabrata oropharyngeal infection in a patient with oral squamous cell carcinoma after COVID-19 infection

886

Candida Glabrata: An emerging threat for the Immunocompromised

887

Candida glabrata: Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans

888

Candida humilis—dominant species in sourdoughs for the production of durum wheat bran flour bread

889

Candida Infection in a Stent Inserted for Tracheal Stenosis After Heart Lung Transplantation

890

Candida infections among neutropenic patients

891

Candida infections: Novel virulence factors and mechanisms of azole resistance

892

Candida isolates from pregnant women and their antifungal susceptibility in a Malaysian tertiary-care hospital

893

Candida isolation from peritoneal fluid: Its role in the outcome of patients with perforation peritonitis

894

Candida krusei development on turbulent flow regimes: Biofilm formation and efficiency of cleaning and disinfection program Original Research Article

895

Candida laryngitis appearing as carcinoma

896

Candida lung abscesses in a renal transplant recipient

897

Candida parapsilosis as a Potent Biocontrol Agent against Growth and Aflatoxin Production by Aspergillus Species

898

Candida parapsilosis endocarditis 8 months after transient candidemia

899

Candida pericarditis: A rare case report

900

Candida Pericarditis: Clinical Profile and Treatment

901

Candida rugosa lipase immobilized by a specially designed microstructure in the PVA/PTFE composite membrane

902

Candida rugosa lipase Lip1–polyethyleneglycol interaction and the relation with its partition in aqueous two-phase systems

903

Candida rugosa lipase mediated multigram synthesis of acid part of S(+)-atliprofen, a new NSAID and molecular modeling studies aimed at predicting selectivity of the enzyme

904

Candida Rugosa lipase reactions in nonionic w/o-microemulsion with a technical surfactant

905

Candida rugosa lipase-catalyzed enantioselective hydrolysis in organic solvents. Convenient preparation of optically pure 2-hydroxy-2-arylethanephosphonates

906

Candida Rugosa lipase-catalyzed kinetic resolution of β-hydroxy-β-arylpropionates and δ-hydroxy-δ-aryl-β-oxo-pentanoates

907

Candida sepsis in surgery

908

Candida species in cutaneous candidiasis patients in the Guilan province in Iran; identified by PCR-RFLP method.

909

Candida species isolated from clinical samples in a tertiary hospital in Honduras: Where is Candida auris?

910

Candida Species Isolated from Various Clinical Samples and Their Susceptibility Patterns to Antifungals

911

Candida theae sp. nov., a new anamorphic beverage-associated member of the Lodderomyces clade

912

Candida tropicalis chorioamnionitis

913

Candida tropicalis osteomyelitis: Case report and review of literature

914

Candida Urinary Tract Infection Among ICU Patients in Isfahan, Iran

915

Candida utilis assimilates oligomeric sugars in rice straw hydrolysate via the Calcium-Capturing-by-Carbonation (CaCCO) process for glutathione- and cell-biomass production

916

Candidacidal Action of CF66I, an Antifungal Compound Produced by Burkholderia Cepacia

917

Candidacidal activities of the glucose oxidase-mediated lactoperoxidase system

918

Candidacy for active surveillance may be associated with improved functional outcomes after prostatectomy

919

Candidacy for active surveillance may be associated with improved functional outcomes after prostatectomy

920

Candidaemia secondary to intravascular catheter colonisation?

921

Candidaemia secondary to intravascular catheter colonisation? – Authorsʹ reply

922

Candidal Leukoplakia on Patient with Removable Denture

923

Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia

924

Candidate ability and platform choice

925

Candidate AIDS vaccine inspires hope

926

Candidate antiretroviral agents for use in postexposure prophylaxis

927

Candidate biomarker discovery in plasma of juvenile cod (Gadus morhua) exposed to crude North Sea oil, alkyl phenols and polycyclic aromatic hydrocarbons (PAHs)

928

Candidate Biomarkers for Targeting in Type 1 Diabetes; A Bioinformatic Analysis of Pancreatic Cell Surface Antigens

929

Candidate blanket concepts for a European fusion power plant study

930

Candidate bone-tissue-engineered product based on human-bone-derived cells and polyurethane scaffold

931

Candidate chiral band in 134La Original Research Article

932

Candidate chromosome 1 disease susceptibility genes for Sjogrenʹs syndrome xerostomia are narrowed by novel NOD.B10 congenic mice

933

Candidate Defense Genes from Rice, Barley, and Maize and Their Association with Qualitative and Quantitative Resistance in Rice

934

Candidate eco-labeling and senate campaign contributions

935

Candidate Gender and Electoral Success in Single Transferable Vote Systems

936

Candidate Gene Analysis for Quantitative Traits Using the Transmission Disequilibrium Test: The Example of the Melanocortin 4-Receptor in Pigs

937

Candidate Gene Association Study of Coronary Artery Calcification in Chronic Kidney Disease: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort)

938

Candidate gene expression associated with geographical variation in cryoprotective dehydration of Megaphorura arctica

939

Candidate gene marker associations with fatty acid profiles in heavy pigs

940

Candidate gene markers associated with somatotropic axis and milk selection

941

Candidate gene markers for sperm quality and fertility of boar

942

Candidate gene markers involved in San Daniele ham quality

943

Candidate Gene Polymorphism for IL-Ry and ChB6 Genes in the Indigenous Chicken of North Western Himalayan State of Himachal Pradesh, India

944

Candidate gene polymorphisms and the 9p21 locus in acute coronary syndromes

945

Candidate gene polymorphisms in solid cancers

946

Candidate Gene Polymorphisms in the Serotonergic Pathway: Influence on Depression Symptomatology in an Elderly Population

947

Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease

948

Candidate genes affecting sheep and goat milk quality

949

Candidate genes and a genome-wide search in Italian families with atopic asthmatic children

950

Candidate genes contributing to the aggressive phenotype of mantle cell lymphoma

951

Candidate genes for behavioural ecology

952

Candidate genes for milk production traits in Portuguese dairy sheep

953

Candidate genes for physical performance in the horse

954

Candidate genes for resistance to Salmonella enteritidis colonization in chickens as detected in a novel genetic cross

955

Candidate genes for resistance to Salmonella enteritidis colonization in chickens as detected in a novel genetic cross

956

Candidate genes in the osteocyte response to mechanical loading in vivo

957

Candidate Genes Polymorphism and Its Association to Prolificacy in Chinese Goats

958

Candidate hypertension-related phenotypes

959

CANDIDATE ISOLATED NEUTRON STARS AND OTHER OPTICALLY BLANK X-RAY FIELDS IDENTIFIED FROM THE ROSAT ALL-SKY AND SLOAN DIGITAL SKY SURVEYS

960

Candidate markers for thromboembolic complications in adult Egyptian patients with β-thalassemia

961

Candidate mechanisms controlling the electrical characteristics of silica/XLPE nanodielectrics

962

Candidate mediators of chondrocyte mechanotransduction via targeted and untargeted metabolomic measurements

963

Candidate Molecular Biomarkers for the Non- Invasive Detection of Colorectal Cancer using Gene Expression Profiling

964

Candidate Notification Scale for Gifted Children in Pre-school Period: Validity and Reliability Studies

965

Candidate Positioning and Entry in a Political Competition

966

Candidate pruning for fast corner detection

967

Candidate quality of care indicators for localized bladder cancer

968

Candidate quality, pressure group endorsements and the nature of political advertising

969

Candidate reactions for mercury detection induced by neutron and alpha particles

970

Candidate reactions for mercury detection induced by neutron and alpha particles

971

Candidate regions of tumor suppressor gene by loss of heterozygosity analysis on chromosome 8p11.1–q13.3 in gastric cancer

972

Candidate tumor suppressor gene SLC5A8 is frequently down-regulated by promoter hypermethylation in prostate tumor

973

CANDIDATE VALENCE: EVIDENCE FROM CONSECUTIVE PRESIDENTIAL ELECTIONS∗

974

Candidate waste forms for immobilisation of waste chloride salt from pyroprocessing of spent nuclear fuel

975

Candidate wasteforms for the immobilization of chloride-containing radioactive waste

976

Candidate working set strategy based SMO algorithm in support vector machine

977

Candidates for Novel RNA Topologies

978

Candidates for therapy: HBV

979

Candidates for U-lines at 1377 and 1394 MHz in IRC+10216: ab initio molecular orbital study

980

Candidates of low-lying dibaryons with strangeness s⩽−5 in a symmetry analysis

981

Candidates’ negotiation of their expertise in job interviews

982

Candidature of equal channel angular pressing for processing of tubular commercial purity-titanium

983

Candidatus Phytoplasma asterisʹ isolate associated with a little leaf disease of pigeon pea in India

984

Candidemia and its Risk Factors in Neonates and Children

985

Candidemia due to Candida guilliermondii in an immuno-compromised infant: a case report and review of literature

986

Candidemia in Children Caused by Uncommon Species of Candida

987

Candidemia in Febrile Neutropenic Patients; a Brief Report

988

Candidemia in patients with prolonged fever in Kashan, Iran

989

Candidemia in pediatric burn patients: Risk factors and outcomes in a retrospective cohort study

990

Candidemia in the Neonatal Intensive Care Unit: Insights on Epidemiology and Antifungal Drug Susceptibility Patterns

991

Candidemia: Changing dynamics from a tertiary care hospital in North India

992

Candidiasis in breast cancer: Tumor progression or not?

993

Candidiasis in Pediatrics; Identification and In vitro Antifungal Susceptibility of the Clinical Isolates

994

Candidose oropharyngée et radiothérapie

995

Candiduria in Hospitalized Patients and Identification of Isolated Candida Species by Morphological and Molecular Methods in Ilam, Iran

996

Candiduria in hospitalized patients in teaching hospitals of Ahvaz

997

Candiduria: A Review of Clinical Significance and Management

998

Candiduria: Prevalence, Identification of Isolated Candida Species and Trends in Antifungal Susceptibility in Hospitalized Patients

999

Candies in hell: women’s experiences of violence in Nicaragua

1000

CANDLE: The New Burnup Strategy

بازگشت